By Ana Espino | Published on March 23, 2026 | 3 min read
Scars, particularly hypertrophic scars and keloids, pose a major medical
problem, impacting the quality of life of many patients following injuries or
surgical procedures. While wound healing is effective in some individuals, it
can be complicated by poor healing and excessive scar tissue formation.
Existing treatments, such as skin grafts or corticosteroid therapies, have
limitations in terms of effectiveness and safety.
Recent research has turned towards
exosomes derived from human placental mesenchymal stem cells (hpMSC-exosomes),
which offer new therapeutic potential in the field of regenerative medicine.
These exosomes, small extracellular vesicles involved in intercellular
communication, possess regenerative and anti-inflammatory properties.
This study, published in Aesthetic
Surgery Journal, aimed to conduct a systematic review and meta-analysis of
preclinical and clinical data on the use of hpMSC-exosomes for wound healing
and scar reduction.
Exosomes: the key to faster healing?
The study included 738 patients
treated with hpMSC-derived exosomes over a 7-year period, covering various
aesthetic and reconstructive indications. The analysis included preclinical
studies, early-phase clinical trials, as well as case series and observational
studies. Data were extracted from scientific databases such as PubMed, Cochrane
Library, EMBASE, and Web of Science.
The meta-analysis of 21 preclinical
studies (involving 323 animals) showed significant results. HpMSC-exosomes
promoted wound healing by stimulating neovascularization, reducing
inflammation, and enhancing collagen production. These exosomes also demonstrated
an immunomodulatory effect, fostering a beneficial anti-inflammatory response.
In clinical studies, the results
were also promising, though limited by the small number of human trials. One
clinical study showed improvement in the appearance of acne scars in patients
who received exosomes combined with CO2 laser treatment, with reduced
post-treatment erythema and a shorter recovery time. Additionally, cases of
accelerated healing of traumatic wounds were observed, with notable
improvements in pain and swelling in patients.
Exosomes: a revolution for wound
healing?
Hypertrophic scars and keloids
represent a complex pathology to treat, and existing treatments are often
insufficient. The objective of this study was to determine if exosomes derived
from human placental mesenchymal stem cells could offer an effective solution
for improving wound healing and treating scars.
The results show significant
potential for hpMSC-exosomes to accelerate wound healing and reduce scar
formation, particularly due to their anti-inflammatory and regenerative
effects. However, large-scale clinical studies are needed to confirm their
efficacy and safety in a clinical setting. The main challenges to overcome
include the standardization of exosome manufacturing processes and obtaining
FDA approval, which requires overcoming regulatory and technical hurdles.
Despite these challenges, this approach offers
promising perspectives for the treatment of chronic wounds and scars and paves
the way for future research on other applications of exosomes in regenerative
medic
Read next: Severely burned patients: where does tissue reconstruction stand?
About the author – Ana EspinoPhD in Immunology, specialized in Virology
As a scientific writer, Ana is passionate about bridging the gap between research and real-world impact. With expertise in immunology, virology, oncology, and clinical studies, she makes complex science clear and accessible. Her mission: to accelerate knowledge sharing and empower evidence-based decisions through impactful communication.
